Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 10/20 | 0.56 |
| ▸ | KDR | P35968 | 5/20 | 0.53 |
| ▸ | FGFR1 | P11362 | 5/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.44 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20548911 | 1.00 | EGFR (0.56) | EGFRKDRFGFR1CYP3A4FGFR3 | |
| SCHEMBL19089422 | 0.99 | EGFR (0.55) | EGFRKDRFGFR1CYP3A4FGFR3 | |
| SCHEMBL19089427 | 0.96 | EGFR (0.52) | EGFRKDRFGFR1 | |
| SCHEMBL19089420 | 0.94 | FGFR1 (0.52) | EGFRKDRFGFR1 | |
| SCHEMBL35210289 | 0.94 | FGFR1 (0.52) | EGFRKDRFGFR1 | |
| SCHEMBL20655722 | 0.93 | EGFR (0.54) | EGFRKDRFGFR1 | |
| SCHEMBL19089421 | 0.90 | FGFR1 (0.55) | EGFRKDRFGFR1 | |
| SCHEMBL20548915 | 0.90 | EGFR (0.56) | EGFRKDRFGFR1CYP3A4FGFR3 | |
| SCHEMBL35210316 | 0.90 | EGFR (0.56) | EGFRKDRFGFR1CYP3A4FGFR3 | |
| SCHEMBL20548767 | 0.87 | FGFR1 (0.47) | EGFRKDRFGFR1FGFR3FGFR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3398939-B1 | ACRYLANILIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF IN PHARMACY | ANCUREALL PHARMACEUTICAL SHANGHAI CO LTD (CN) | 2026-05-06 | — | — | EP | claimed |
| EP-3398939-B1 | ACRYLANILIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF IN PHARMACY | ANCUREALL PHARMACEUTICAL SHANGHAI CO LTD (CN) | 2026-05-06 | — | — | EP | disclosed |